222 related articles for article (PubMed ID: 26247697)
41. Immunohistochemistry 2015: Protein correlates of molecular alterations and predictive testing.
Hornick JL
Semin Diagn Pathol; 2015 Sep; 32(5):323-4. PubMed ID: 26250936
[No Abstract] [Full Text] [Related]
42. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
Arnedos M; Vielh P; Soria JC; Andre F
J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
[TBL] [Abstract][Full Text] [Related]
43. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
44. Clinical assessment of the efficacy of anti-cancer treatment: current status and perspectives.
Zhang JJ; Meng Q; Chang W; Wan CH
Chin J Cancer; 2010 Feb; 29(2):234-8. PubMed ID: 20109358
[TBL] [Abstract][Full Text] [Related]
45. Epistatic interactions and drug response.
Weigelt B; Reis-Filho JS
J Pathol; 2014 Jan; 232(2):255-63. PubMed ID: 24105606
[TBL] [Abstract][Full Text] [Related]
46. Tumor heterogeneity and personalized cancer medicine: are we being outnumbered?
Cirkel GA; Gadellaa-van Hooijdonk CG; Koudijs MJ; Willems SM; Voest EE
Future Oncol; 2014 Feb; 10(3):417-28. PubMed ID: 24559448
[TBL] [Abstract][Full Text] [Related]
47. Cancer biomarkers: selecting the right drug for the right patient.
Kelloff GJ; Sigman CC
Nat Rev Drug Discov; 2012 Feb; 11(3):201-14. PubMed ID: 22322254
[TBL] [Abstract][Full Text] [Related]
48. Establishment of Drug-resistant Cell Lines as a Model in Experimental Oncology: A Review.
Amaral MVS; DE Sousa Portilho AJ; DA Silva EL; DE Oliveira Sales L; DA Silva Maués JH; DE Moraes MEA; Moreira-Nunes CA
Anticancer Res; 2019 Dec; 39(12):6443-6455. PubMed ID: 31810908
[TBL] [Abstract][Full Text] [Related]
49. Selected Articles from This Issue.
Clin Cancer Res; 2020 May; 26(10):2279. PubMed ID: 32414759
[No Abstract] [Full Text] [Related]
50. Combining targeted drugs to stop resistant tumors.
Kaiser J
Science; 2011 Mar; 331(6024):1542-5. PubMed ID: 21436437
[No Abstract] [Full Text] [Related]
51. [Evolution of the parameters indicating response to drug therapy: from regression to complete control of the disease and the symptoms].
Cascinu S; Camisa R; D'Angelo A; Salvagni S
Tumori; 2002; 88(6):A7-9. PubMed ID: 12597158
[No Abstract] [Full Text] [Related]
52. The European Union and personalised cancer medicine.
Hickman JA; Tannock IF; Meheus L; Hutchinson L
Eur J Cancer; 2021 Jun; 150():95-98. PubMed ID: 33892410
[TBL] [Abstract][Full Text] [Related]
53. Personalising the treatment of prostate cancer.
Gunjur A
Lancet Oncol; 2015 Dec; 16(16):e592. PubMed ID: 26549591
[No Abstract] [Full Text] [Related]
54. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer.
Zhang I; Zaorsky NG; Palmer JD; Mehra R; Lu B
Lancet Oncol; 2015 Oct; 16(13):e510-21. PubMed ID: 26433824
[TBL] [Abstract][Full Text] [Related]
55. Probabilistic medicine: a pre-emptive approach is needed for cancer therapeutic risk mitigation.
Hicks JK; McLeod HL
Biomark Med; 2019 Aug; 13(12):987-990. PubMed ID: 31385527
[No Abstract] [Full Text] [Related]
56. APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types regardless of p53 or MMR status.
Scott BJ; Qutob S; Liu QY; Ng CE
Int J Cancer; 2009 Sep; 125(5):1193-204. PubMed ID: 19444912
[TBL] [Abstract][Full Text] [Related]
57. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
Gillet JP; Gottesman MM
Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
[No Abstract] [Full Text] [Related]
58. The Evolving Landscape of HER2 Targeting in Breast Cancer.
Moasser MM; Krop IE
JAMA Oncol; 2015 Nov; 1(8):1154-61. PubMed ID: 26204261
[TBL] [Abstract][Full Text] [Related]
59. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
MacConaill LE; Lindeman NI; Rollins BJ
JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
[No Abstract] [Full Text] [Related]
60. Cancer and natural selection.
Fillon M
J Natl Cancer Inst; 2012 Dec; 104(23):1773-4. PubMed ID: 23213180
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
